心房細動患者におけるWatchman FLXデバイスとDOACの比較に関するランダム化試験の根拠とデザイン

Karら（Sun、）はこの問題を研究しました。

www.synapsesocial.com/papers/69cd9897ee48e5fa6293c3a9 — DOI: https://doi.org/10.1016/j.ahj.2023.05.022

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation· 2014 · 975 citations
2. Edoxaban versus Warfarin in Patients with Atrial Fibrillation· 2013 · 5,095 citations
3. Apixaban versus Warfarin in Patients with Atrial Fibrillation· 2011 · 8,871 citations
4. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation· 2011 · 9,363 citations
5. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation· 2021 · 266 citations